Quotient Limited to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on June 22nd

Rhea-AI Summary

Quotient Limited (NASDAQ: QTNT) will release its fiscal fourth quarter and full year financial results for the period ending March 31, 2022, on June 22, 2022. The results will be disseminated before the market opens, followed by a conference call at 8:00 AM ET. The call will feature CEO Manuel O. Méndez and CFO Ali J. Kiboro, with dial-in details provided for various regions. Quotient specializes in transfusion diagnostics, focusing on innovative solutions with its proprietary MosaiQ technology aimed at enhancing laboratory efficiencies and clinical practices.

Positive

• Quotient's MosaiQ technology is positioned as a game-changer in diagnostics.
• Focus on operational cost savings and workflow improvements for laboratories.

Negative

• None.

JERSEY, Channel Islands, June 17, 2022 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal fourth quarter and full year ended March 31, 2022 will be released before market open on Wednesday, June 22, 2022.

Title:	Quotient Fourth Quarter and Full Year 2021 Financial Results and Conference Call
Speakers:	Manuel O. Méndez, Chief Executive Officer Ali J. Kiboro, Chief Financial Officer
Date:	Wednesday, June 22, 2022
Time:	8:00am ET/ 14:00 CET
Conference Call Dial-in Details:	International: 201-689-8560 Switzerland: 0800 835 525 United Kingdom: 0800 756 3429 US: 877-407-0784 Conference ID: 13729874
Webcast:	Webcast Link - Click Here Quotient Events & Presentations

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.

About Quotient Limited

Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that it believes reshape the way diagnostics are practiced. The MosaiQ solution, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. The MosaiQ solution is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and create operational cost savings to laboratories around the world. Quotient's operations are based in Switzerland, Scotland, US and the UAE.

The Quotient logo, Quotient MosaiQ and MosaiQ are registered trademarks or trademarks of Quotient Limited and its subsidiaries in various jurisdictions.

CONTACT: Investor Relations, ir@quotientbd.com; +41 22 545 52 26

FAQ

When will Quotient Limited announce its financial results for Q4 and full year 2021?

Quotient Limited will announce its financial results on June 22, 2022.

What time is the conference call for Quotient Limited's financial results?

The conference call is scheduled for 8:00 AM ET on June 22, 2022.

Who will be speaking during Quotient Limited's financial results conference call?

CEO Manuel O. Méndez and CFO Ali J. Kiboro will be speaking.

How can I access the webcast for Quotient Limited's conference call?

The webcast can be accessed via the provided link and should be tuned in 15 minutes prior to the start time.

What technology does Quotient Limited use for diagnostics?

Quotient Limited utilizes the MosaiQ solution, a fully automated testing platform.